Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

217 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
L-deprenyl and physostigmine for the treatment of Alzheimer's disease.
Marin DB, Bierer LM, Lawlor BA, Ryan TM, Jacobson R, Schmeidler J, Mohs RC, Davis KL. Marin DB, et al. Among authors: mohs rc. Psychiatry Res. 1995 Oct 16;58(3):181-9. doi: 10.1016/0165-1781(95)02714-8. Psychiatry Res. 1995. PMID: 8570774 Clinical Trial.
4-Aminopyridine in the treatment of Alzheimer's disease.
Davidson M, Zemishlany Z, Mohs RC, Horvath TB, Powchik P, Blass JP, Davis KL. Davidson M, et al. Among authors: mohs rc. Biol Psychiatry. 1988 Mar 1;23(5):485-90. doi: 10.1016/0006-3223(88)90020-0. Biol Psychiatry. 1988. PMID: 2830918 Clinical Trial.
Cholinergic strategies in the treatment of Alzheimer's disease.
Davidson M, Stern RG, Bierer LM, Horvath TB, Zemishlani Z, Markofsky R, Mohs RC. Davidson M, et al. Among authors: mohs rc. Acta Psychiatr Scand Suppl. 1991;366:47-51. doi: 10.1111/j.1600-0447.1991.tb03109.x. Acta Psychiatr Scand Suppl. 1991. PMID: 1897375 Review.
Antemortem markers of Alzheimer's disease.
Hollander E, Mohs RC, Davis KL. Hollander E, et al. Among authors: mohs rc. Neurobiol Aging. 1986 Sep-Oct;7(5):367-407. doi: 10.1016/0197-4580(86)90164-8. Neurobiol Aging. 1986. PMID: 3537824 Review.
217 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page